These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18034787)

  • 1. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion.
    Garratty G
    Vox Sang; 2008 Feb; 94(2):87-95. PubMed ID: 18034787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells.
    Nacharaju P; Boctor FN; Manjula BN; Acharya SA
    Transfusion; 2005 Mar; 45(3):374-83. PubMed ID: 15752155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs.
    Garratty G
    Transfus Med Rev; 2004 Oct; 18(4):245-56. PubMed ID: 15497125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research advance on universal red blood cell engineering].
    Tan YX; Ji SP; Gong F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):814-9. PubMed ID: 21729578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying the red cell surface: towards an ABO-universal blood supply.
    Olsson ML; Clausen H
    Br J Haematol; 2008 Jan; 140(1):3-12. PubMed ID: 17970801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased immunorejection in unmatched blood transfusions by attachment of methoxypolyethylene glycol on human red blood cells and the effect on D antigen.
    Tan Y; Qiu Y; Xu H; Ji S; Li S; Gong F; Zhang Y
    Transfusion; 2006 Dec; 46(12):2122-7. PubMed ID: 17176324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies.
    Long C; Hara H; Pawlikowski Z; Koike N; d'Arville T; Yeh P; Ezzelarab M; Ayares D; Yazer M; Cooper DK
    Transfusion; 2009 Nov; 49(11):2418-29. PubMed ID: 19624491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells.
    Chapanian R; Constantinescu I; Rossi NA; Medvedev N; Brooks DE; Scott MD; Kizhakkedathu JN
    Biomaterials; 2012 Nov; 33(31):7871-83. PubMed ID: 22840223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal crossreacting anti-A, B antibody.
    Kajii E; Usuda S; Ikemoto S
    Nihon Hoigaku Zasshi; 1990 Jun; 44(3):227-33. PubMed ID: 2232333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pegylated hamster red blood cells on microcirculation.
    Chen PC; Huang W; Stassinopoulos A; Cheung AT
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(4):295-309. PubMed ID: 18649167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiolation mediated pegylation platform to generate functional universal red blood cells.
    Nacharaju P; Manjula BN; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):107-18. PubMed ID: 17364475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic glycolipid modification of red blood cell membranes.
    Frame T; Carroll T; Korchagina E; Bovin N; Henry S
    Transfusion; 2007 May; 47(5):876-82. PubMed ID: 17465953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
    Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
    Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method to optimize PEG-coating of red blood cells.
    Hashemi-Najafabadi S; Vasheghani-Farahani E; Shojaosadati SA; Rasaee MJ; Armstrong JK; Moin M; Pourpak Z
    Bioconjug Chem; 2006; 17(5):1288-93. PubMed ID: 16984140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells.
    Heathcote D; Carroll T; Wang JJ; Flower R; Rodionov I; Tuzikov A; Bovin N; Henry S
    Transfusion; 2010 Mar; 50(3):635-41. PubMed ID: 19912581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: atypical presentation of anti-Rg(a).
    Kahwash E; Talwalkar SS; Leonard J; Lockwood W
    Ann Clin Lab Sci; 2005; 35(1):100-4. PubMed ID: 15830717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of normal red blood cells to become Tn-activated when transfused into a patient with Tn-polyagglutination.
    Reid ME; Ellisor SS; Swanson J; Edwards G; Stanik F
    Am J Med Technol; 1980 Sep; 46(9):670-2. PubMed ID: 7416196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell antigens as functional molecules and obstacles to transfusion.
    Garratty G; Telen MJ; Petz LD
    Hematology Am Soc Hematol Educ Program; 2002; ():445-62. PubMed ID: 12446436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buccal mucosal cell immunohistochemistry: a simple method of determining the ABH phenotype of baboons, monkeys, and pigs.
    Busch J; Specht S; Ezzelarab M; Cooper DK
    Xenotransplantation; 2006 Jan; 13(1):63-8. PubMed ID: 16497213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
    Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC
    Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.